Michael A. Ferguson, MD
Director, Pediatric Nephrology Fellowship Program; Director, Renal Hypertension Program; Co-Director, Center for Midaortic Syndrome and Renovascular Hypertension; Nephrologist, Division of Nephrology
Assistant Professor in Pediatrics, Harvard Medical School
Image
Michael A. Ferguson, MD
Director, Pediatric Nephrology Fellowship Program; Director, Renal Hypertension Program; Co-Director, Center for Midaortic Syndrome and Renovascular Hypertension; Nephrologist, Division of Nephrology
Assistant Professor in Pediatrics, Harvard Medical School
Medical Services
Languages
English
Education
Undergraduate School
St. Lawrence University
1992
Canton
NY
Medical School
University of Vermont College of Medicine
2001
Burlington
VT
Internship
Pediatrics
University of Vermont/Fletcher Allen Health Care
2002
Burlington
VT
Residency
Pediatrics
University of Vermont/Fletcher Allen Health Care
2004
Burlington
VT
Residency
Chief Resident in Pediatrics
University of Vermont/Fletcher Allen Health Care
2005
Burlington
VT
Fellowship
Pediatric Nephrology
Boston Children's Hospital
2008
Boston
MA
Media
Caregiver Profile
Meet Dr. Michael Ferguson
Certifications
American Board of Pediatrics (General)
American Board of Pediatrics (Nephrology)
Publications
Lesion network mapping predicts post-stroke behavioural deficits and improves localization. View Abstract
Mutations of the Transcriptional Corepressor ZMYM2 Cause Syndromic Urinary Tract Malformations. View Abstract
Correction to: Prospective pediatric study comparing glomerular filtration rate estimates based on motion-robust dynamic contrast-enhanced magnetic resonance imaging and serum creatinine (eGFR) to 99mTc DTPA. View Abstract
Prospective pediatric study comparing glomerular filtration rate estimates based on motion-robust dynamic contrast-enhanced magnetic resonance imaging and serum creatinine (eGFR) to 99mTc DTPA. View Abstract
Risk Factors for Mortality in Critically Ill Children Requiring Renal Replacement Therapy. View Abstract
Renal replacement therapy in the pediatric cardiac intensive care unit. View Abstract
Whole-Exome Sequencing Identifies Causative Mutations in Families with Congenital Anomalies of the Kidney and Urinary Tract. View Abstract
Should ACE inhibitors and ARBs be used in combination in children? View Abstract
African trypanosomes evade immune clearance by O-glycosylation of the VSG surface coat. View Abstract
Mesenteric Artery Growth Improves Circulation (MAGIC) in Midaortic Syndrome. View Abstract
Whole Exome Sequencing Reveals a Monogenic Cause of Disease in ˜43% of 35 Families With Midaortic Syndrome. View Abstract
Tissue expander-stimulated lengthening of arteries for the treatment of midaortic syndrome in children. View Abstract
The authors reply. View Abstract
Whole Exome Sequencing of Patients with Steroid-Resistant Nephrotic Syndrome. View Abstract
Whole exome sequencing frequently detects a monogenic cause in early onset nephrolithiasis and nephrocalcinosis. View Abstract
Analysis of 24 genes reveals a monogenic cause in 11.1% of cases with steroid-resistant nephrotic syndrome at a single center. View Abstract
Catheter-Directed Thrombolysis in a Child with Bilateral Renal Artery Graft Thrombosis. View Abstract
Acute Kidney Injury After Pediatric Cardiac Surgery: A Secondary Analysis of the Safe Pediatric Euglycemia After Cardiac Surgery Trial. View Abstract
The effect of an electronic health record-based tool on abnormal pediatric blood pressure recognition. View Abstract
In-Clinic Blood Pressure Prediction of Normal Ambulatory Blood Pressure Monitoring in Pediatric Hypertension Referrals. View Abstract
Mutations in SLC26A1 Cause Nephrolithiasis. View Abstract
Increased platelet mitochondrial respiration after cardiac arrest and resuscitation as a potential peripheral biosignature of cerebral bioenergetic dysfunction. View Abstract
Evaluation and treatment of hypertensive crises in children. View Abstract
Prevalence of Monogenic Causes in Pediatric Patients with Nephrolithiasis or Nephrocalcinosis. View Abstract
In vitro generation of human pluripotent stem cell derived lung organoids. View Abstract
Commentary on "protective effect of pulmonary hypertension against right-sided tamponade in pericardial effusion". View Abstract
Evaluation of the diagnostic accuracy of prototype rapid tests for human African trypanosomiasis. View Abstract
Lead optimization of a pyrazole sulfonamide series of Trypanosoma brucei N-myristoyltransferase inhibitors: identification and evaluation of CNS penetrant compounds as potential treatments for stage 2 human African trypanosomiasis. View Abstract
Serum proteome of nonalcoholic fatty liver disease: a multimodal approach to discovery of biomarkers of nonalcoholic steatohepatitis. View Abstract
Cost effectiveness of percutaneous closure versus medical therapy for cryptogenic stroke in patients with a patent foramen ovale. View Abstract
Percutaneous closure versus medical therapy alone for cryptogenic stroke patients with a patent foramen ovale: meta-analysis of randomized controlled trials. View Abstract
Identification of sVSG117 as an immunodiagnostic antigen and evaluation of a dual-antigen lateral flow test for the diagnosis of human African trypanosomiasis. View Abstract
Proteomic selection of immunodiagnostic antigens for Trypanosoma congolense. View Abstract
Clinical predictors and impact of ambulatory blood pressure monitoring in pediatric hypertension referrals. View Abstract
Midaortic syndrome: 30 years of experience with medical, endovascular and surgical management. View Abstract
Rational use of antihypertensive medications in children. View Abstract
High-dose ibuprofen is not associated with increased biomarkers of kidney injury in patients with cystic fibrosis. View Abstract
Aorto-mesenteric and renal allograft transplant: a novel treatment for midaortic syndrome. View Abstract
A novel treatment for the midaortic syndrome. View Abstract
Mild postoperative acute kidney injury and outcomes after surgery for congenital heart disease. View Abstract
Fulminant thrombotic microangiopathy in pediatrics: where diagnostic and therapeutic dilemmas meet. View Abstract
Established and emerging markers of kidney function. View Abstract
Urinary liver-type fatty acid-binding protein predicts adverse outcomes in acute kidney injury. View Abstract
Urinary biomarkers for sensitive and specific detection of acute kidney injury in humans. View Abstract
Biomarkers of nephrotoxic acute kidney injury. View Abstract
Biomarkers of acute kidney injury. View Abstract
Comparison of Fy(b) status as determined serologically and genetically. View Abstract
Locations